Preparation and characterization of drop pills of effective part from safflower for anti-Parkinson’s disease

doi:10.5246/jcps.2019.01.004

Abstract

Abstract:

Parkinson's disease (PD) is a common degenerative disease of the central nervous system, and the pathologic features are mainly degeneration of substantianigra and dopamine neurons. Studies have shown that safflower flavonoid extract (SAFE) exhibits the neuroprotective effect. In this study, the safflower flavonoid extract drop pills (SAFE-DPs) for anti-PD were prepared by the heating and melting method using SAFE and matrix PEG6000. The performances of the pills were evaluated with powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM) and dissolution testing. The analysis results demonstrated an amorphous state for SAFE dispersion in the matrix PEG6000 without any chemical reaction. The SAFE-DPs demonstrated acceptable chemical and physical stability irrespective of the manufacturing process and the storage period. Dissolution testing in three dissolution media (pH 1.0, pH 6.8 and pH 7.5) indicated that SAFE-DPs had excellent dissolution property. The transport of Kaempferol-3-rutinoside (K3R) on the Caco-2 monolayer and the absorption of K3R in situ intestinal perfusion revealed that the principal component of SAFE had a good transport and absorption capacity. Therefore, the drop pills had better release and absorption in the gastrointestinal tract, corresponding with the pharmacological and pharmacodynamic results for PD in vivo.

Key words: Safflower flavonoid extract, Parkinson’s disease, Solid dispersion, Drop pills, Kaempferol-3-O-rutinoside, Characterizations

CLC Number:

R943

Supporting:

Shixuan Cheng, Yingcong Ma, Yujie Liu, Ning Pang, Ji Li, Meng Sha, Rutong Ren, Nuramatjan Ablat, Jing Cao, Yi Sun, Xiaoping Pu, Min Ye, Xianrong Qi. Preparation and characterization of drop pills of effective part from safflower for anti-Parkinson’s disease[J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(1): 27-39.

References

[1] Lesage, S.; Brice, A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 2009, 18, R48-59.

[2] Van Dijk, K.D.; Teunissen, C.E.; Drukarch, B.; Jimenez, C.R.; Groenewegen, H.J.; Berendse, H.W.; Van De Berg, W.D. Diagnostic cerebrospinal fluid biomarkers for Parkinson’s disease: a pathogenetically based approach. Neurobiol. Dis. 2010, 39, 229-241.

[3] Stocchi, F.; Marconi, S. Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio). Clin. Neuropharmacology. 2010, 33, 198-203.

[4] Borovac, J.A. Side effects of a dopamine agonist therapy for Parkinson’s disease: a mini-review of clinical pharmacology. Yale J. Biol. Med. 2016, 89, 37-47.

[5] Zhou, X.; Tang, L.; Xu, Y.; Zhou, G.; Wang, Z. Towards a better understanding of medicinal uses of Carthamustinctorius L. in traditional Chinese medicine: a phytochemical and phar-macological review. J. Ethnopharmacol. 2014, 151, 27-43.

[6] Si, W.; Yang, W.; Guo, D.; Wu, J.; Zhang, J.; Qiu, S.; Yao, C.; Cui, Y.; Wu, W. Selective ion monitoring of quinochalcone C-glycoside markers for the simultaneous identification of Carthamustinctorius L. in eleven Chinese patent medicines by UHPLC/QTOF MS. J. Pharm. Biomed. Anal. 2016, 117, 510-521.

[7] Kazuma, K.; Takahashi, T.; Sato, K.; Takeuchi, H.; Matsumoto, T.; Okuno, T. Quinochalcones and flavonoids from fresh florets in different cultivars of Carthamustinctorius L. Biosci. Biotechnol. Biochem. 2000, 64, 1588-1599.

[8] Fan, L.; Zhao, H.Y.; Xu, M.; Zhou, L.; Guo, H.; Han, J.; Wang, B.R.; Guo, D.A. Qualitative evaluation and quantitative determination of 10 major active components in Carthamustinctorius L. by high-performance liquid chromatography coupled with diode array detector. J. Chromatogr. A. 2009, 1216, 2063-2070.

[9] Li, H.X.; Han, S.Y.; Wang, X.W.; Ma, X.; Zhang, K.; Wang, L.; Ma, Z.Z.; Tu, P.F. Effect of the carthamins yellow from Carthamustinctorius L. on hemorheological disorders of blood stasis in rats. Food Chem. Toxicol. 2009, 47, 1797-1802.

[10] Wu, S.; Yue, Y.; Tian, H.; Li, Z.; Li, X.; He, W.; Ding, H. Carthamus red from Carthamustinctorius L. exerts antioxidant and hepatoprotective effect against CCl(4)-induced liver dam-age in rats via the Nrf2 pathway. J. Ethnopharmacol. 2013, 148, 570-578.

[11] Li, R.; Guo, M.; Zhang, G.; Xu, X.; Li, Q. Nicotiflorin reduces cerebral ischemic damage and upregulates endothelial nitric oxide synthase in primarily cultured rat cerebral blood vessel endothelial cells. J. Ethnopharmacol. 2006, 107, 143-150.

[12] Huang, J.L.; Fu, S.T.; Jiang, Y.Y.; Cao, Y.B.; Guo, M.L.; Wang, Y.; Xu, Z. Protective effects of Nicotiflorin on reducing memory dysfunction, energy metabolism failure and oxidative stress in multi-infarct dementia model rats. Pharmacol. Biochem. Behav. 2007, 86, 741-748.

[13] Ren, R.; Shi, C.; Cao, J.; Sun, Y.; Zhao, X.; Guo, Y.; Wang, C.; Lei, H.; Jiang, H.; Ablat, N.; Xu, J.; Li, W.; Ma, Y.; Qi, X.; Ye, M.; Pu, X.; Han, H. Neuroprotective Effects of A Standardized Flavonoid Extract of Safflower Against Neurotoxin-Induced Cellular and Animal Models of Parkinson’s Disease. Sci. Rep. 2016, 6, 22135.

[14] Im, J.Y.; Lee, K.W.; Junn, E.; Mouradian, M.M. DJ-1 protects against oxidative damage by regulating the thioredoxin/ASK1 complex. Neurosci. Res. (Shannon, Irel.). 2010, 67, 203-208.

[15] Li, S.; Sun, Y.; Zhao, X.; Pu, X.P. Expression of the Parkinson’s disease protein DJ-1 during the differentiation of neural stem cells. Brain Res. 2012, 1468, 84-93.

[16] Qu, W.; Fan, L.; Kim, Y.C.; Ishikawa, S.; Iguchi-Ariga, S.M.M.; Pu, X.-P.; Ariga, H. Kaempferol Derivatives Prevent Oxidative Stress-Induced Cell Death in a DJ-1-Dependent Manner. J. Pharmacol. Sci. (Amsterdam, Neth.). 2009, 110, 191-200.

[17] Wu, Q.; Ye, M.; Pu, X.P. Neuroprotective effect of CTE, an extract from traditional Chinese medicine, in a mouse model of MPTP-induced Parkinson’s disease. Chin. J. New Drugs. 2011, 20, 355-358.

[18] Ablat, N.; Lv, D.; Ren, R.; Xiaokaiti, Y.; Ma, X.; Zhao, X.; Sun, Y.; Lei, H.; Xu, J.; Ma, Y.; Qi, X.; Ye, M.; Xu, F.; Han, H; Pu, X. Neuroprotective Effects of a Standardized Flavonoid Extract from Safflower against a Rotenone-Induced Rat Model of Parkinson’s Disease. Molecules. 2016, 21, 1107.

[19] Chokshi, R.J.; Zia, H.; Sandhu, H.K.; Shah, N.H.; Malick, W.A. Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution: pros and cons. Drug Delivery. 2007, 14, 33-45.

[20] Oh, D.H.; Park, Y.J.; Kang, J.H.; Yong, C.S.; Choi, H.G. Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change. Drug Delivery. 2011, 18, 46-53.

[21] Joshi, H.N.; Tejwani, R.W.; Davidovich, M.; Sahasrabudhe, V.P.; Jemal, M.; Bathala, M.S.; Varia, S.A.; Serajuddin, A.T.M. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int. J. Pharm. (Amsterdam, Neth.). 2004, 269, 251-258.

[22] Fasinu, P.; Pillay, V.; Ndesendo, V.M.; Du Toit, L.C.; Choonara, Y.E. Diverse approaches for the enhancement of oral drug bioavailability. Biopharm. Drug Dispos. 2011, 32, 185-209.

[23] Meng, Z.J.; Zhang, M.; Wei, S.N.; Bi, X.J.; Hatch, G.M.; Gu. J.K.; Chen, L. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability. Int. J. Pharm. (Amsterdam, Neth.). 2014, 467, 50-59.

[24] Knopp, M.M.; Nguyen, J.H.; Becker, C.; Francke, N.M.; Jorgensen, E.B.; Holm, P.; Holm, R.; Mu, H.; Rades, T.; Langguth, P. Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib: PVP amorphous solid dispersions. Eur. J. Pharm. Biopharm. 2016, 101, 145-151.

[25] Yang, Y.; Zhao, Z.; Wang, Y.; Yang, L.; Liu, D.; Yang, X.; Pan, W. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system. Int. J. Pharm. (Amsterdam, Neth.). 2016, 506, 340-350.

[26] Guo, H.; Liu, A.H.; Li, L.; Guo, D.A. Simultaneous determination of 12 major constituents in Forsythia suspensa by high performance liquid chromatography--DAD method. J. Pharm. Biomed. Anal. 2007, 43, 1000-1006.

[27] Zhu, M.L.; Liang, X.L.; Zhao, L.J.; Liao, Z.G.; Zhao, G.W.; Cao, Y.C.; Zhang, J.; Luo, Y. Elucidation of the transport mechanism of baicalin and the influence of a Radix AngelicaeDahuricae extract on the absorption of baicalin in a Caco-2 cell monolayer model. J. Ethnopharmacol. 2013, 150, 553-559.

[28] Ding, W.; Hou, X.; Cong, S.; Zhang, Y.; Chen, M.; Lei, J.; Meng, Y.; Li, X.; Li, G. Co-delivery of honokiol, a constituent of Magnolia species, in a self-microemulsifying drug delivery system for improved oral transport of lipophilic sirolimus. Drug Delivery. 2016, 23, 2513-2523.

[29] Lin, Q.; Ling, L.Q.; Guo, L.; Gong, T.; Sun, X.; Zhang, Z.R. Intestinal absorption characteristics of imperialine: in vitro and in situ assessments. Acta. Pharmacol. Sin. 2015, 36, 863-873.

[30] Adebisi, A.O.; Kaialy, W.; Hussain, T.; Al-Hamidi, H.; Nokhodchi, A.; Conway, B.R.; Asare-Addo, K. An assessment of triboelectrification effects on co-ground solid dispersions of carbamazepine. Powder Technol. 2016, 292, 342-350.

[31] Borba, P.A.; Pinotti, M.; De Campos, C.E.; Pezzini, B.R.; Stulzer, H.K. Sodium alginate as a potential carrier in solid dispersion formulations to enhance dissolution rate and apparent water solubility of BCS II drugs. Carbohydr. Polym. 2016, 137, 350-359.

[32] Newa, M.; Bhandari, K.H.; Kim, J.A.; Yoo, B.K.; Choi, H.G.; Yong, C.S.; Woo, J.S.; Lyoo, W.S. Preparation and evaluation of fast dissolving ibuprofen-polyethylene glycol 6000 solid dispersions. Drug Delivery. 2008, 15, 355-364.

[33] Yee, S. In vitro permeability across Caco-2 cells (Colonic) can predict in vivo (small intestinal) absorption in Man—Fact or Myth. Pharm. Res. 1997, 14, 763-766.

[34] Jager, A.K.; Saaby, L. Flavonoids and the CNS. Molecules. 2011, 16, 1471-1485.